Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-02

FDA Approved: MATULANE — Supplemental Application (Leadiant Biosciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for MATULANE (procarbazine hydrochloride) submitted by Leadiant Biosciences, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MATULANE (Procarbazine hydrochloride)

Snippet

SUPPL AP for MATULANE (PROCARBAZINE HYDROCHLORIDE)